本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zura Bio

1.64
-0.0400-2.38%
盘后1.63-0.0100-0.61%19:56 EDT
成交量:46.54万
成交额:77.78万
市值:1.01亿
市盈率:-2.29
高:1.75
开:1.68
低:1.62
收:1.68
数据加载中...
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/25

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/15

重要事件披露

Form 8-K - Current report
2023/09/12

SEC问询函

Form CORRESP - Correspondence
2023/09/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/08

SEC问询函

Form CORRESP - Correspondence
2023/08/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/24

SEC问询函

Form CORRESP - Correspondence
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/08/11

SEC问询函

Form CORRESP - Correspondence
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/22

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/21

SEC问询函

Form CORRESP - Correspondence
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals